cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.5938249
title: Supplementary Material for: Case Reports of Acne and Homeopathy

description: <b><i>Background:</i></b> Acne vulgaris is a self-limiting disorder of the pilosebaceous unit. The aesthetic aspect of the disorder may provoke depression and diminish the quality of life. A number of agents are used for acne treatment, e.g., retinoids, antibiotics, benzoic acid, azelaic acid, and hormones. These agents have side-effects, sometimes severe ones. <b><i>Case Reports:</i></b> Presented are 2 cases of severe acne treated with individualized homeopathic medicines. Both patients were treated using the classical method of homeopathy, i.e., a single medicine based on the patient's individual characteristics was prescribed. The cases were documented photographically at onset and during the course of treatment. Both patients went into remission following treatment, and long-term follow-up suggested that the therapy remained efficacious long after cessation of treatment. No significant side effects were noted. <b><i>Conclusions:</i></b> Homeopathic medicines may be useful as stand-alone treatment of patients with severe acne vulgaris. A case series suggested a remission rate of more than 80% using individualized homeopathic treatment. The treatment remained efficacious long after cessation and is not accompanied by significant side-effects. It is to be hoped that this presentation will stimulate research interest into homeopathic medicines as stand-alone or adjunct treatments of acne.
DOI: 10.17045/sthlmuni.5938246
title: Open Access status of articles at Stockholm University 2012-2017

description: This dataset contains free to read/open access status of scholarly journal articles from Stockholm University (Sweden) published between 2012-2017. The data published in xlsx and csv format. Only journal articles with a known DOI are included. The status of free/open access of the articles were checked manually and then compared to the Unpaywall/oaDOi database (https://unpaywall.org/data) in February 2018. The data was fetched with the help of the Unpaywall/oaDOI API: https://unpaywall.org/api/v2<br>Definitions of the columns in the data file:<br><b>Article:</b>DOI: DOI id of the ariclesu:DIVA PID: id of the article in the Stockholm University publication database (DiVA: http://su.diva-portal.org/)Journal: Name of the artcleYear: Publication year<br><b>Manually checked data:</b>Free to read at publisher homepage: 1 if the full-text of the article is free to read without registration at the publisher's homepageOA: 1 if the article has some kind of OA licenseLicense: Specification of the OA license (type of Creative Commons license, or "Other license"Gold OA journal: 1 if the journal is fully open accessPublisher: name of the publisher<br><b>Data from oaDOI</b>DOI found in oaDOI: 1 if the DOI is found in the oaDOI databaseoaDOI found something open: 1 if the oaDOI database found an open version availableFree to read at publisher homepage according to oaDOI: 1 if there is a free to read available version at the publisher's homepage according to oaDOIOA at publisher according to oaDOI best locationoaDOI best location: best free location according to oaDOIoaDOI data_standard: 1 or 2 according to oaDOI oaDOI license: license from the oaDOI databaseoaDOI license (standardized format): license type converted to the format of the column "License". License types other than Creative Commons are categorized as "Other license".<br>Note: since many things were checked manually/half-automatically, some errors are inevitable. Furthermore all data was only accurate at the time of the check.
DOI: 10.6084/m9.figshare.5938210
title: Supplementary Material for: Symptom-Specific Effects of Psychotherapy versus Combined Therapy in the Treatment of Mild to Moderate Depression: A Network Approach

description: Medicine
DOI: 10.6084/m9.figshare.5938174
title: Visualising U.S. gun laws

description: These files provide the data used for the following post on Genealogical World of Networks (http:///phylonetworks.blogspot.com/)<br><br> <b>Grimm GW</b>. Posted 5/3/2018. Visualizing U.S. gun laws. <i>The Genealogical World of Phylogenetic Networks</i> (ed. by D. Morrison). http://phylonetworks.blogspot.fr/2018/03/visualizing-us-gun-laws.html<br><br>The data matrix scores GunsToCarry's breakdown of U.S. gun legislation as a set of 17 binary and ternary characters, which is then used to infer inter-state pairwise (mean/Hamming) distances. <br><br>I provide the data matrix in two formats:<br><b>*.nex</b> — A fully annotated version (character states labelled) generated with (and optimised for) Mesquite (https://mesquiteproject.wikispaces.com/)<br><b>*.simple.nex </b>— Version in (old) NEXUS format (data block) showing the set-up for the distance analysis such as the used weighting scheme<br><br>Results are provided raw and graphically enhanced<br><b>*.dst</b> — the resultant pairwise distance matrix in (extended) PHYLIP format<br><b>*.dist</b> — the resultant neighbour-net, Splits-NEXUS-formatted (can be opened and visualised with SplitsTree, www.splitstree.org, and R/phangorn, https://github.com/KlausVigo/phangorn)<br><b>*.png</b> – graphically enhanced versions of the resultant neighbour-net as shown in the original post and the related long-read at Res.I.P. (http:///phylonetworks.blogspot.com/)<br><br>Listed programmes are free-to-use software, *.simple.nex and *.dst files can also be viewed with any text-editor (*.nex and *.dist can be viewed but include complex additional code-lines)<br><br>
DOI: 10.6084/m9.figshare.5938174.v1
title: Visualising U.S. gun laws

description: These files provide the data used for the following post on Genealogical World of Networks (http:///phylonetworks.blogspot.com/)<br><br> <b>Grimm GW</b>. Posted 5/3/2018. Visualizing U.S. gun laws. <i>The Genealogical World of Phylogenetic Networks</i> (ed. by D. Morrison). http://phylonetworks.blogspot.fr/2018/03/visualizing-us-gun-laws.html<br><br>The data matrix scores GunsToCarry's breakdown of U.S. gun legislation as a set of 17 binary and ternary characters, which is then used to infer inter-state pairwise (mean/Hamming) distances. <br><br>I provide the data matrix in two formats:<br><b>*.nex</b> — A fully annotated version (character states labelled) generated with (and optimised for) Mesquite (https://mesquiteproject.wikispaces.com/)<br><b>*.simple.nex </b>— Version in (old) NEXUS format (data block) showing the set-up for the distance analysis such as the used weighting scheme<br><br>Results are provided raw and graphically enhanced<br><b>*.dst</b> — the resultant pairwise distance matrix in (extended) PHYLIP format<br><b>*.dist</b> — the resultant neighbour-net, Splits-NEXUS-formatted (can be opened and visualised with SplitsTree, www.splitstree.org, and R/phangorn, https://github.com/KlausVigo/phangorn)<br><b>*.png</b> – a graphically enhanced version of the resultant neighbour-net as shown in the original post<br><br>Listed programmes are free-to-use software, *.simple.nex and *.dst files can also be viewed with any text-editor (*.nex and *.dist can be viewed but include complex additional code-lines)<br><br>
DOI: 10.6084/m9.figshare.5938174.v3
title: Visualising U.S. gun laws

description: These files provide the data used for the following post on Genealogical World of Networks (http:///phylonetworks.blogspot.com/)<br><br> <b>Grimm GW</b>. Posted 5/3/2018. Visualizing U.S. gun laws. <i>The Genealogical World of Phylogenetic Networks</i> (ed. by D. Morrison). http://phylonetworks.blogspot.fr/2018/03/visualizing-us-gun-laws.html<br><br>The data matrix scores GunsToCarry's breakdown of U.S. gun legislation as a set of 17 binary and ternary characters, which is then used to infer inter-state pairwise (mean/Hamming) distances. <br><br>I provide the data matrix in two formats:<br><b>*.nex</b> — A fully annotated version (character states labelled) generated with (and optimised for) Mesquite (https://mesquiteproject.wikispaces.com/)<br><b>*.simple.nex </b>— Version in (old) NEXUS format (data block) showing the set-up for the distance analysis such as the used weighting scheme<br><br>Results are provided raw and graphically enhanced<br><b>*.dst</b> — the resultant pairwise distance matrix in (extended) PHYLIP format<br><b>*.dist</b> — the resultant neighbour-net, Splits-NEXUS-formatted (can be opened and visualised with SplitsTree, www.splitstree.org, and R/phangorn, https://github.com/KlausVigo/phangorn)<br><b>*.png</b> – graphically enhanced versions of the resultant neighbour-net as shown in the original post and the related long-read at Res.I.P. (http:///phylonetworks.blogspot.com/)<br><br>Listed programmes are free-to-use software, *.simple.nex and *.dst files can also be viewed with any text-editor (*.nex and *.dist can be viewed but include complex additional code-lines)<br><br>
DOI: 10.6084/m9.figshare.5938174.v2
title: Visualising U.S. gun laws

description: These files provide the data used for the following post on Genealogical World of Networks (http:///phylonetworks.blogspot.com/)<br><br> <b>Grimm GW</b>. Posted 5/3/2018. Visualizing U.S. gun laws. <i>The Genealogical World of Phylogenetic Networks</i> (ed. by D. Morrison). http://phylonetworks.blogspot.fr/2018/03/visualizing-us-gun-laws.html<br><br>The data matrix scores GunsToCarry's breakdown of U.S. gun legislation as a set of 17 binary and ternary characters, which is then used to infer inter-state pairwise (mean/Hamming) distances. <br><br>I provide the data matrix in two formats:<br><b>*.nex</b> — A fully annotated version (character states labelled) generated with (and optimised for) Mesquite (https://mesquiteproject.wikispaces.com/)<br><b>*.simple.nex </b>— Version in (old) NEXUS format (data block) showing the set-up for the distance analysis such as the used weighting scheme<br><br>Results are provided raw and graphically enhanced<br><b>*.dst</b> — the resultant pairwise distance matrix in (extended) PHYLIP format<br><b>*.dist</b> — the resultant neighbour-net, Splits-NEXUS-formatted (can be opened and visualised with SplitsTree, www.splitstree.org, and R/phangorn, https://github.com/KlausVigo/phangorn)<br><b>*.png</b> – graphically enhanced versions of the resultant neighbour-net as shown in the original post<br><br>Listed programmes are free-to-use software, *.simple.nex and *.dst files can also be viewed with any text-editor (*.nex and *.dist can be viewed but include complex additional code-lines)<br><br>
DOI: 10.6084/m9.figshare.5938159
title: A gelatin/collagen/polycaprolactone scaffold for skin regeneration

description: A tissue-engineered skin substitute, based on bioplastic gelatin (“G”), collagen (“C”), and poly(e-caprolactone) (PCL; “P”), was developed.
DOI: 10.6084/m9.figshare.5938159.v1
title: A gelatin/collagen/polycaprolactone scaffold for skin regeneration

description: A tissue-engineered skin substitute, based on bioplastic gelatin (“G”), collagen (“C”), and poly(e-caprolactone) (PCL; “P”), was developed.
DOI: 10.6084/m9.figshare.5938150
title: WCorpus mysql database with texts of 3 writers

description: WCorpus mysql database with texts of three Russian writers: Chekhov, Tolstoy and Dostoevsky. <br><br>This database has size 4.4 GB, and 396 MB packed by 7-Zip.<br><br>See slides about this research: <br><br>Alexander Kirillov, Andrew Krizhanovsky. 2018. Calculation of contexts semantic similarity in WSD task solving (In Russian). URL: https://goo.gl/9ak6Gt<br><br>Two GitHub projects were created in this research: wcorpus and wcorpus.py with fillowing links:<br>1) https://github.com/componavt/wcorpus<br>2) https://github.com/componavt/wcorpus.py<br>
DOI: 10.6084/m9.figshare.5938150.v1
title: WCorpus mysql database with texts of 3 writers

description: WCorpus mysql database with texts of three Russian writers: Chekhov, Tolstoy and Dostoevsky. <br><br>This database has size 4.4 GB, and 396 MB packed by 7-Zip.<br><br>See slides about this research: <br><br>Alexander Kirillov, Andrew Krizhanovsky. 2018. Calculation of contexts semantic similarity in WSD task solving (In Russian). URL: https://goo.gl/9ak6Gt<br><br>Two GitHub projects were created in this research: wcorpus and wcorpus.py with fillowing links:<br>1) https://github.com/componavt/wcorpus<br>2) https://github.com/componavt/wcorpus.py<br>
DOI: 10.6084/m9.figshare.5938141
title: Efficacy and safety of tamsulosin 0.4 mg single pills for treatment of Asian patients with symptomatic benign prostatic hyperplasia with lower urinary tract symptoms: a randomized, double-blind, phase 3 trial

description: <b>Objective:</b> To verify the efficacy and safety of tamsulosin 0.4 mg and tamsulosin 0.2 mg compared with those of placebo in patients with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). <b>Methods:</b> A total of 494 patients from multiple centers participated in this double-blind, randomized, phase 3 trial. Eligible patients were randomly assigned to the tamsulosin 0.4 mg group, tamsulosin 0.2 mg group or placebo group. The International Prostate Symptom Score (IPSS), maximum flow rate (<i>Qmax</i>), post-void residual (PVR) urine volume, blood pressure, heart rate and adverse events were compared among the three groups at 4, 8 and 12 weeks. <b>Results:</b> A total of 494 BPH patients were analyzed. There were no differences in the baseline characteristics among the three groups. After 12 weeks of treatment, total IPSS was improved in the 0.2 mg and 0.4 mg tamsulosin groups; however, the extent of improvement was greater in the 0.4 mg group than in the 0.2 mg group (0.4 mg: −9.59 vs. 0.2 mg: −5.61; least-squares mean difference [95% confidence interval]: −3.95 [−5.01, −2.89], <i>p</i> p Qmax and PVR were improved in the 0.4 mg and 0.2 mg groups; however, the differences were not statistically significant between treatment groups. No patients experienced any serious adverse effects in any of the three groups. <b>Conclusions:</b> Tamsulosin 0.4 mg and 0.2 mg appear to be superior to placebo treatment, and tamsulosin 0.4 mg is more effective than 0.2 mg in terms of total IPSS improvement. Tamsulosin 0.4 mg has favorable efficacy and tolerability in Asian men with symptomatic BPH. <b>ClinicalTrials.gov Identifier:</b> NCT02390882.
DOI: 10.6084/m9.figshare.5938141.v2
title: Efficacy and safety of tamsulosin 0.4 mg single pills for treatment of Asian patients with symptomatic benign prostatic hyperplasia with lower urinary tract symptoms: a randomized, double-blind, phase 3 trial

description: <b>Objective:</b> To verify the efficacy and safety of tamsulosin 0.4 mg and tamsulosin 0.2 mg compared with those of placebo in patients with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). <b>Methods:</b> A total of 494 patients from multiple centers participated in this double-blind, randomized, phase 3 trial. Eligible patients were randomly assigned to the tamsulosin 0.4 mg group, tamsulosin 0.2 mg group or placebo group. The International Prostate Symptom Score (IPSS), maximum flow rate (<i>Qmax</i>), post-void residual (PVR) urine volume, blood pressure, heart rate and adverse events were compared among the three groups at 4, 8 and 12 weeks. <b>Results:</b> A total of 494 BPH patients were analyzed. There were no differences in the baseline characteristics among the three groups. After 12 weeks of treatment, total IPSS was improved in the 0.2 mg and 0.4 mg tamsulosin groups; however, the extent of improvement was greater in the 0.4 mg group than in the 0.2 mg group (0.4 mg: −9.59 vs. 0.2 mg: −5.61; least-squares mean difference [95% confidence interval]: −3.95 [−5.01, −2.89], <i>p</i> p Qmax and PVR were improved in the 0.4 mg and 0.2 mg groups; however, the differences were not statistically significant between treatment groups. No patients experienced any serious adverse effects in any of the three groups. <b>Conclusions:</b> Tamsulosin 0.4 mg and 0.2 mg appear to be superior to placebo treatment, and tamsulosin 0.4 mg is more effective than 0.2 mg in terms of total IPSS improvement. Tamsulosin 0.4 mg has favorable efficacy and tolerability in Asian men with symptomatic BPH. <b>ClinicalTrials.gov Identifier:</b> NCT02390882.
DOI: 10.6084/m9.figshare.5938141.v1
title: Efficacy and safety of tamsulosin 0.4mg single pills for the treatment in Asian patients with symptomatic benign prostatic hyperplasia of lower urinary tract symptoms: a randomized, double-blind, phase 3 trial

description: <b>Objective:</b> To verify the efficacy and safety of tamsulosin 0.4 mg and tamsulosin 0.2 mg compared with those of placebo in patients with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). <b>Methods:</b> A total of 494 patients from multiple centers participated in this double-blind, randomized, phase 3 trial. The eligible patients were randomly assigned to the tamsulosin 0.4 mg group, tamsulosin 0.2 mg group, or placebo group. The International Prostate Symptom Score (IPSS), maximum ﬂow rate (Qmax), post-void residual (PVR) urine volume, blood pressure, heart rate, and adverse events were compared among the three groups at 4, 8, and 12 weeks. <b>Results:</b> A total of 494 BPH patients were analyzed. There were no differences in the baseline characteristics among the three groups. After 12 weeks of treatment, the total IPSS was improved in the 0.2 mg and 0.4 mg tamsulosin groups; however, the extent of improvement was greater in the 0.4 mg group than in the 0.2 mg group (0.4 mg: −9.59 vs. 0.2 mg: −5.61; least-squares mean difference (95% confidence interval): −3.95 (-5.01, -2.89), (<i>p</i> &lt; 0.0001). In addition, in the patients with severe symptom (IPSS ≥ 20), the total IPSS was improved the most in the 0.4 mg group (−11.27 ± 5.00, <i>p</i> &lt; 0.0001). Qmax and PVR were improved in the 0.4 mg and 0.2 mg groups; however, the differences were not statistically significant between treatment groups. No patients experienced any serious adverse effects in any of the three groups. <b>Conclusion:</b> Tamsulosin 0.4 mg and 0.2 mg appears to be superior to placebo treatment, and tamsulosin 0.4 mg is more effective than 0.2 mg in terms of total IPSS improvement. Tamsulosin 0.4 mg has a favorable efficacy and tolerability in Asian men with symptomatic BPH.
DOI: 10.6084/m9.figshare.5938099
title: Oral L-citrulline and Transresveratrol Supplementation Improves Erectile Function in Men with Phosphodieserase 5 Inhibitors: Randomized, Double-blind, Placebo-controlled Crossover Pilot Study.

description: This is a first study that combination therapy of L-citrulline and transresveratrol are effective for ED patients with unsatisfied efficacy by on-demand use of PDE5i.
DOI: 10.6084/m9.figshare.5938099.v1
title: Oral L-citrulline and Transresveratrol Supplementation Improves Erectile Function in Men with Phosphodieserase 5 Inhibitors: Randomized, Double-blind, Placebo-controlled Crossover Pilot Study.

description: This is a first study that combination therapy of L-citrulline and transresveratrol are effective for ED patients with unsatisfied efficacy by on-demand use of PDE5i.
DOI: 10.6084/m9.figshare.5938093
title: Additional file 5: of Developmental transcriptomics of the brittle star Amphiura filiformis reveals gene regulatory network rewiring in echinoderm larval skeleton evolution

description: Details on fuzzy clustering. This file includes the data for Fig. 5. It shows the classification of TFs of A. filiformis and S. purpuratus into the four modes of expression. (XLSX 69 kb)
DOI: 10.6084/m9.figshare.5938093.v1
title: Additional file 5: of Developmental transcriptomics of the brittle star Amphiura filiformis reveals gene regulatory network rewiring in echinoderm larval skeleton evolution

description: Details on fuzzy clustering. This file includes the data for Fig. 5. It shows the classification of TFs of A. filiformis and S. purpuratus into the four modes of expression. (XLSX 69 kb)
DOI: 10.6084/m9.figshare.5938090
title: Additional file 4: of Developmental transcriptomics of the brittle star Amphiura filiformis reveals gene regulatory network rewiring in echinoderm larval skeleton evolution

description: Stable genes used for normalization. This file includes a list of genes that have a standard deviation smaller than 0.01 and whose average was used as normalization for the expression of the residual genes. (XLSX 70 kb)
DOI: 10.6084/m9.figshare.5938090.v1
title: Additional file 4: of Developmental transcriptomics of the brittle star Amphiura filiformis reveals gene regulatory network rewiring in echinoderm larval skeleton evolution

description: Stable genes used for normalization. This file includes a list of genes that have a standard deviation smaller than 0.01 and whose average was used as normalization for the expression of the residual genes. (XLSX 70 kb)
DOI: 10.6084/m9.figshare.5938087
title: Additional file 3: of Developmental transcriptomics of the brittle star Amphiura filiformis reveals gene regulatory network rewiring in echinoderm larval skeleton evolution

description: All vs all search for 901 skeletogenic genes. This file includes the detailed results of Fig. 2 and Additional file 1: Figure S5 to show in detail which genes are parts of the different overlaps between the four species. (XLSX 197 kb)
DOI: 10.6084/m9.figshare.5938087.v1
title: Additional file 3: of Developmental transcriptomics of the brittle star Amphiura filiformis reveals gene regulatory network rewiring in echinoderm larval skeleton evolution

description: All vs all search for 901 skeletogenic genes. This file includes the detailed results of Fig. 2 and Additional file 1: Figure S5 to show in detail which genes are parts of the different overlaps between the four species. (XLSX 197 kb)
DOI: 10.6084/m9.figshare.5938069
title: Additional file 2: of A novel canine histiocytic sarcoma cell line: initial characterization and utilization for drug screening studies

description: Description of primary and secondary antibodies. (XLSX 27 kb)
DOI: 10.6084/m9.figshare.5938069.v1
title: Additional file 2: of A novel canine histiocytic sarcoma cell line: initial characterization and utilization for drug screening studies

description: Description of primary and secondary antibodies. (XLSX 27 kb)
DOI: 10.6084/m9.figshare.5938063
title: Additional file 1: of A novel canine histiocytic sarcoma cell line: initial characterization and utilization for drug screening studies

description: Genetic profile of BD cell line genotyped using of a panel of microsatellite markers. (XLSX 31 kb)
DOI: 10.34740/kaggle/dsv/1451764
title: COVID-19 cases by Continent
DOI: 10.6084/m9.figshare.5938063.v1
title: Additional file 1: of A novel canine histiocytic sarcoma cell line: initial characterization and utilization for drug screening studies

description: Genetic profile of BD cell line genotyped using of a panel of microsatellite markers. (XLSX 31 kb)
DOI: 10.6084/m9.figshare.5938036
title: MOESM5 of H2 drives metabolic rearrangements in gas-fermenting Clostridium autoethanogenum

description: Additional file 5. SBML file for the GEM iCLAU786.
DOI: 10.6084/m9.figshare.5938036.v1
title: MOESM5 of H2 drives metabolic rearrangements in gas-fermenting Clostridium autoethanogenum

description: Additional file 5. SBML file for the GEM iCLAU786.
DOI: 10.6084/m9.figshare.5938024
title: MOESM4 of H2 drives metabolic rearrangements in gas-fermenting Clostridium autoethanogenum

description: Additional file 4. Results of quantitative proteome analysis. Table S5. List of SIL-proteins with differential expression (q value 1.5) between syngas and CO, and high-H2 CO and CO, respectively; Table S8. Absolute protein expression levels as MS signal intensities.
DOI: 10.6084/m9.figshare.5938024.v1
title: MOESM4 of H2 drives metabolic rearrangements in gas-fermenting Clostridium autoethanogenum

description: Additional file 4. Results of quantitative proteome analysis. Table S5. List of SIL-proteins with differential expression (q value 1.5) between syngas and CO, and high-H2 CO and CO, respectively; Table S8. Absolute protein expression levels as MS signal intensities.